Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers.

Forslund A, Zeng Z, Qin LX, Rosenberg S, Ndubuisi M, Pincas H, Gerald W, Notterman DA, Barany F, Paty PB.

Mol Cancer Res. 2008 Feb;6(2):205-11. doi: 10.1158/1541-7786.MCR-07-0239.

2.

The Role of MDM2 Amplification and Overexpression in Tumorigenesis.

Oliner JD, Saiki AY, Caenepeel S.

Cold Spring Harb Perspect Med. 2016 Jun 1;6(6). pii: a026336. doi: 10.1101/cshperspect.a026336. Review.

3.

TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value.

Deben C, Deschoolmeester V, Lardon F, Rolfo C, Pauwels P.

Crit Rev Oncol Hematol. 2016 Mar;99:63-73. doi: 10.1016/j.critrevonc.2015.11.019. Epub 2015 Nov 28. Review.

PMID:
26689115
4.

Translating p53 into the clinic.

Cheok CF, Verma CS, Baselga J, Lane DP.

Nat Rev Clin Oncol. 2011 Jan;8(1):25-37. doi: 10.1038/nrclinonc.2010.174. Epub 2010 Oct 26. Review.

PMID:
20975744

Supplemental Content

Support Center